169 related articles for article (PubMed ID: 31147200)
41. Cigarette smoke extract induced exosome release is mediated by depletion of exofacial thiols and can be inhibited by thiol-antioxidants.
Benedikter BJ; Volgers C; van Eijck PH; Wouters EFM; Savelkoul PHM; Reynaert NL; Haenen GRMM; Rohde GGU; Weseler AR; Stassen FRM
Free Radic Biol Med; 2017 Jul; 108():334-344. PubMed ID: 28359953
[TBL] [Abstract][Full Text] [Related]
42. [Multicenter, controlled, double-blind study of the efficacy and tolerance of Vectrine (erdostein) versus placebo in the treatment of stabilized chronic bronchitis with hypersecretion].
Aubier M; Berdah L
Rev Mal Respir; 1999 Sep; 16(4):521-8. PubMed ID: 10549062
[TBL] [Abstract][Full Text] [Related]
43. Mucolytics and antioxidant activity.
Strapková A; Nosál'ová G; Franová S
Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
[TBL] [Abstract][Full Text] [Related]
44. [Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
Gillissen A
Pneumologie; 2011 Sep; 65(9):549-57. PubMed ID: 21761386
[TBL] [Abstract][Full Text] [Related]
45. [Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Karapolat S
Tuberk Toraks; 2009; 57(2):244-5; author reply 245-6. PubMed ID: 19714520
[No Abstract] [Full Text] [Related]
46. Effects of erdosteine on cyclosporin-A-induced nephrotoxicity.
Tutanc M; Arica V; Yılmaz N; Nacar A; Zararsiz I; Basarslan F; Tutanc OD; Nacar E
Hum Exp Toxicol; 2012 Jun; 31(6):565-73. PubMed ID: 21813577
[TBL] [Abstract][Full Text] [Related]
47. Thiol reducing compounds prevent human amylin-evoked cytotoxicity.
Konarkowska B; Aitken JF; Kistler J; Zhang S; Cooper GJ
FEBS J; 2005 Oct; 272(19):4949-59. PubMed ID: 16176268
[TBL] [Abstract][Full Text] [Related]
48. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
49. [Effects of inhalation of a mucolytic agent on the respiratory function of children with an asthmatic syndrome].
Logvinoff-Poidatz MM; Geubelle F
Rev Med Liege; 1974 Aug; 29(16):467-71. PubMed ID: 4428105
[No Abstract] [Full Text] [Related]
50. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
51. Mucolytics and the critically ill patient: help or hindrance?
Connolly MA
AACN Clin Issues; 1995 May; 6(2):307-15. PubMed ID: 7743433
[TBL] [Abstract][Full Text] [Related]
52. Effects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung disease.
Marchioni CF; Moretti M; Muratori M; Casadei MC; Guerzoni P; Scuri R; Fregnan GB
Lung; 1990; 168(5):285-93. PubMed ID: 2126836
[TBL] [Abstract][Full Text] [Related]
53. Mucolytics, expectorants, and mucokinetic medications.
Rubin BK
Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
[TBL] [Abstract][Full Text] [Related]
54. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
55. Drugs affecting clearance of middle ear secretions: a perspective for the management of otitis media with effusion.
Brown DT; Potsic WP; Marsh RR; Litt M
Ann Otol Rhinol Laryngol Suppl; 1985; 117():3-15. PubMed ID: 2859825
[TBL] [Abstract][Full Text] [Related]
56. Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.
Sener G; Sehirli AO; Toklu HZ; Yuksel M; Ercan F; Gedik N
Pediatr Surg Int; 2007 Mar; 23(3):233-41. PubMed ID: 17216233
[TBL] [Abstract][Full Text] [Related]
57. Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine.
Tunc T; Oter S; Güven A; Topal T; Kul M; Korkmaz A; Ongürü O; Sarici U
J Gastroenterol Hepatol; 2009 Apr; 24(4):681-7. PubMed ID: 19054265
[TBL] [Abstract][Full Text] [Related]
58. Protective role of sulfhydryl reagents in oxidant lung injury.
Patterson CE; Rhoades RA
Exp Lung Res; 1988; 14 Suppl():1005-19. PubMed ID: 3061790
[TBL] [Abstract][Full Text] [Related]
59. Depressant effects of ambroxol and erdosteine on cytokine synthesis, granule enzyme release, and free radical production in rat alveolar macrophages activated by lipopolysaccharide.
Jang YY; Song JH; Shin YK; Han ES; Lee CS
Pharmacol Toxicol; 2003 Apr; 92(4):173-9. PubMed ID: 12753420
[TBL] [Abstract][Full Text] [Related]
60. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
